| Old Articles: <Older 8551-8560 Newer> |
 |
The Motley Fool July 21, 2005 Tom Taulli |
Amgen One-Ups Genentech New Medicare regulations look to be harmless, and as a result, Amgen is off to the races. Still, investing in biotech is always dicey.  |
The Motley Fool July 21, 2005 John Reeves |
Kodak Goes Negative: Fool by Numbers Eastman Kodak released second quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights...  |
The Motley Fool July 21, 2005 Stephen D. Simpson |
Tiger Lilly or Wilting Daisy? For now, Lilly seems to me to be a middle-of-the-road type of pharmaceutical stock. There are plenty of worse ideas out there, but there are better ideas, as well.  |
The Motley Fool July 21, 2005 Jeremy MacNealy |
Oakley's Future Looks Bright The eyewear outfit raises full-year guidance once more. Its stock is pushing upward to levels not seen since 2002, which may make its price too dazzling for some.  |
The Motley Fool July 21, 2005 Nathan Parmelee |
A Piece of Boston at New York & Co. Acquisition of Jasmine chain adds a potential growth component to an already intriguing retail company.  |
The Motley Fool July 21, 2005 Rich Smith |
Manpower Goes to Work Job growth equals profits growth for the temporary staffer. Investors, take note.  |
The Motley Fool July 21, 2005 Rich Smith |
Honeywell's Sweet Success The industrial giant wows the crowd. Investors, take note.  |
The Motley Fool July 21, 2005 Rich Smith |
Kinder Morgan's Surprise The gas pipeliner has a prize in every package. Investors, take note.  |
The Motley Fool July 21, 2005 Rich Smith |
Dueling Fools: Sirius Bear Rebuttal If Sirius' management isn't going to -- or can't afford to -- insure the interests of its shareholders, you can't afford to own Sirius. At any price.  |
The Motley Fool July 21, 2005 Rick Aristotle Munarriz |
Dueling Fools: Sirius Bull Rebuttal Sirius continues to grow faster than its own public projections. It recently revised its subscriber count forecast from 2.5 million up to 2.7 million users by the end of this year. Investors, take note.  |
| <Older 8551-8560 Newer> Return to current articles. |